“It’s not often that a single product catapults a whole industry upward,” writes business newspaper Handelsblatt, but then again the product offered by German coronavirus vaccine developer BioNTech is no ordinary one.
The effect of the coronavirus pandemic on the plans of entrepreneurs setting up new companies in Germany has been far less than many feared.
EUR 111 billion in turnover and a 12 percent rise compared with a year ago – those are the record-setting figures published by the Association of the Chemicals Industry (VCI) for the first half of 2021.
A university medical clinic in the western German city of Bonn has come up with a coronavirus test, called LAMP-Seq, that is both ultrasensitive and scalable, so that thousands of samples can be analyzed simultaneously. That gives it a huge potential for use in companies, schools and kindergartens.
As the coronavirus disrupted economic life in Germany and around the world in 2020, many people feared that waves of businesses would go bankrupt. But figures compiled by the German Savings Banks Association (DSGV) for business newspaper Handelsblatt suggest that the worst of those anxieties were unfounded.
Germany’s renowned Fraunhofer Institute has developed a process for recycling protective anti-Covid-19 masks.
With the rise in anti-coronavirus vaccinations, numbers of Covid-19 cases have significantly dropped in Germany and elsewhere. But protective masks are almost certainly to stay in great demand – both because of state rules and personal preferences.
Rare but serious cases of blood clotting in people inoculated by the vector vaccines produced by AstraZeneca and Johnson&Johnson have been one obstacle to the international immunization campaigns against Covid-19.
Jörn Holtmeier, managing director of the Association of the German Trade Fair Industry (AUMA), discusses how the sector is coping with coronavirus restrictions.
As cases of Covid-19 surged again across the world last fall, German authorities took quick action to limit infection numbers. The measures were typical of Germany’s response to the unprecedented situation: attempting to balance economic concerns with necessary and timely health interventions.
